iTAg Tetramer/APC - Mamu-A*01 SIV gag (CTPYDINQM)

Catalog No:
MBL-TS-5003-2

Availability: 12PM PT on Dec. 3, 2024

Formerly Catalog No.: TB-5003-2

Nonhuman primates (NHP) resemble humans in multiple ways including similarities in genomics,  immunogenetics, and age-related changes in immune function. These characteristics are critical to the establishment of a relevant model in which to conduct preclinical studies to optimize the efficacy and safety of  therapeutic approaches. Importantly, NHPs are vital preclinical models for viruses as viral infections are frequently associated with the same pathologies. Hence, NHPs are immune models to study viral vaccine efficacy and antiviral therapeutic safety and efficacy and to understand aspects of viral pathogenesis. Over numerous preclinical studies for human viral diseases, NHPs have demonstrated to be a beneficial benchmark for investigating human viral infections. MHC Tetramers are used for the detection of antigen-specific T-cell populations. MHC-peptide tetramer complexes recognize antigen specific T-cells at the single cell level, allowing for accurate measurements of the functional immune response in cancer, infectious diseases, and autoimmune diseases.  Due to their increased avidity, MHC tetramers stably bind to cognate TcRs and are evaluated using flow cytometry.

Product Specifications
Application FC
Reactivity Monkey
Conjugation APC
Peptide Sequence CTPYDINQM

Citations for iTAg Tetramer/APC - Mamu-A*01 SIV gag (CTPYDINQM) – 1 Found
Cecchinato, Valentina; Tryniszewska, Elzbieta; Ma, Zhong Min; Vaccari, Monica; Boasso, Adriano; Tsai, Wen-Po; Petrovas, Constantinos; Fuchs, Dietmar; Heraud, Jean-Michel; Venzon, David; Shearer, Gene M; Koup, Richard A; Lowy, Israel; Miller, Christopher J; Franchini, Genoveffa. Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. Journal Of Immunology (Baltimore, Md. : 1950). 2008;180(8):5439-47.  PubMed